Patrocinado
Novo Nordisk CEO to step down amid market challenges and stock plunge
Postado
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia Mais
RITES eyes revenue growth through export focus, quality assurance & business diversification: CMD
RITES Ltd is focusing on increased export orders and diversifying its Quality Assurance (QA)...
Illegal remittance flows suspected in central bank Governor appointment: Koirala
KATHMANDU: Nepali Congress leader Dr. Shekhar Koirala has directly linked the suspected influx of...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese
